445 related articles for article (PubMed ID: 34438351)
1. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.
Chiu YH; Spierings J; de Jong PA; Hoesein FM; Grutters JC; van Laar JM; Voortman M
Respir Med; 2021 Oct; 187():106579. PubMed ID: 34438351
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
3. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography.
Afeltra A; Zennaro D; Garzia P; Gigante A; Vadacca M; Ruggiero A; Dardes N; Navajas MF; Zobel BB; Amoroso A
Scand J Rheumatol; 2006; 35(5):388-94. PubMed ID: 17062440
[TBL] [Abstract][Full Text] [Related]
5. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF; Snyder LD; Hage CA; Singer JP; Ware LB; Cantu E; Oyster M; Kalman L; Christie JD; Kawut SM; Bernstein EJ
J Heart Lung Transplant; 2021 May; 40(5):351-358. PubMed ID: 33637413
[TBL] [Abstract][Full Text] [Related]
6. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study.
Jacob J; Bartholmai BJ; Rajagopalan S; Brun AL; Egashira R; Karwoski R; Kokosi M; Wells AU; Hansell DM
BMC Med; 2016 Nov; 14(1):190. PubMed ID: 27876024
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases.
Chen X; Guo J; Yu D; Jie B; Zhou Y
Front Pharmacol; 2021; 12():754851. PubMed ID: 34712141
[No Abstract] [Full Text] [Related]
9. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
10. Pneumothorax in connective tissue disease-associated interstitial lung disease.
Nishimoto K; Fujisawa T; Yoshimura K; Enomoto Y; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Sumikawa H; Johkoh T; Suda T
PLoS One; 2020; 15(7):e0235624. PubMed ID: 32634173
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
[TBL] [Abstract][Full Text] [Related]
12. Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases.
Hernandez-Gonzalez F; Prieto-González S; Brito-Zeron P; Cuerpo S; Sanchez M; Ramirez J; Agustí C; Lucena CM; Paradela M; Grafia I; Espinosa G; Sellares J
Medicine (Baltimore); 2020 Jan; 99(4):e18589. PubMed ID: 31977850
[TBL] [Abstract][Full Text] [Related]
13. Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
Kwon BS; Choe J; Chae EJ; Hwang HS; Kim YG; Song JW
Respir Res; 2021 Oct; 22(1):282. PubMed ID: 34719401
[TBL] [Abstract][Full Text] [Related]
14. Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.
Choi WI; Lee DY; Choi HG; Lee CW
Respir Res; 2019 Jun; 20(1):117. PubMed ID: 31182103
[TBL] [Abstract][Full Text] [Related]
15. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Tian M; Huang W; Ren F; Luo L; Zhou J; Huang D; Tang L
Clin Rheumatol; 2020 Feb; 39(2):575-583. PubMed ID: 31758424
[TBL] [Abstract][Full Text] [Related]
17. Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study.
Chiu YH; Koops MFM; Voortman M; van Es HW; Langezaal LCM; Welsing PMJ; Jamnitski A; Wind AE; van Laar JM; Grutters JC; Spierings J
Front Med (Lausanne); 2023; 10():1106560. PubMed ID: 36923009
[TBL] [Abstract][Full Text] [Related]
18. Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease.
Sun D; Wang Y; Liu Q; Wang T; Li P; Jiang T; Dai L; Jia L; Zhao W; Cheng Z
Respir Res; 2022 Jan; 23(1):4. PubMed ID: 34996461
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria.
Bozzao F; Tomietto P; Baratella E; Kodric M; Cifaldi R; Della Porta R; Prearo I; Pirronello SMG; Confalonieri P; Ruaro B; Fischetti F; Fabris B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
